Post-transplant biliary complications using liver grafts from deceased donors older than 70 years: Retrospective case-control study

Table 1 Donor characteristics

	BC (n = 21)	Non-BC (n = 229)	P value
Age (yr)	77.5 ± 5.8	77.2 ± 5.2	0.757
Sex (female), n (%)	7 (33.3)	138 (60.3)	0.017
BMI (kg/m2)	26.1 ± 5.1	27.4 ± 4.7	0.366
Obesity (BMI ≥ 30), n (%)	5 (23.8)	57 (25.2)	0.409
ICU stay (h)	34 ± 24	24 ± 24	0.964
Cause of death, n (%)
Cerebrovascular	14 (66.7)	183 (79.9)	0.773
Head trauma	5 (23.8)	36 (15.7)
Other	2 (9.5)	10 (4.4)
Hypertension, n (%)	13 (61.9)	131 (57.2)	0.677
Diabetes, n (%)	5 (23.8)	47 (20.5)	0.452
Cardiac arrest, n (%)	4 (19.0)	13 (5.7)	0.043
Hemodynamic instability, n (%)	9 (42.9)	67 (29.3)	0.195
Norepinephrine use, n (%)	15 (71.4)	163 (71.2)	0.981
Laboratory values
Serum glucose (mg/dL)	158 ± 42	174 ± 70	0.378
Serum creatinine (mg/dL)	0.9 ± 0.5	0.8 ± 0.4	0.148
Serum sodium (mEq/L)	145 ± 7	146 ± 8	0.402
AST (IU/L)	23 ± 17	28 ± 19	0.191
ALT (IU/L)	22 ± 19	26 ± 22	0.444
GGT (IU/L)	24 ± 49	21 ± 35	0.447
Platelets/m3	134 ± 84	172 ± 86	0.016
Prothrombin rate (%)	77 ± 16	72 ± 23	0.426
Partial thromboplastin time (s)	30 ± 6	30.5 ± 7.3	0.495
Steatosis (biopsy findings) , n (%)
Microsteatosis	6 (28.6)	39 (17.0)	0.509
Mild macrosteatosis	4 (19.0)	61 (26.6)
Moderate macrosteatosis	0	8 (3.5)
Cold ischemia time (min)	442 ± 225	429 ± 235	0.783
Warm ischemia time (min)	55 ± 15	55 ± 15	0.486
Preservation solution, n (%)
Celsior	18 (85.7)	189 (82.5)	0.496
Belzer	3 (14.3)	40 (17.5)

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMI: Body mass index; GGT: Gamma-glutamyl transpeptidase.